ObjectiveTo evaluate the efficacy and safety of Janus kinase （JAK） inhibitors combined with Chinese herbal medicine （CHM） in treating rheumatoid arthritis （RA）. MethodsClinical data from 169 RA patients were retrospectively collected. Among them， 71 cases received JAK inhibitors as the control group， while 98 cases received JAK inhibitors plus CHM as the observation group， both treated for 24 weeks. The rheumatoid factor （RF）， cyclic citic peptide antibody （anti-CCP）， erythrocyte sedimentation rate （ESR）， C-reactive protein （CRP）， and white blood cell count （WBC） were recorded before and after treatment. Databases including CNKI， Wanfang， VIP， PubMed and Web of Science were searched from inception till August 31st， 2025 for randomized controlled trials （RCTs） on the combined use of JAK inhibitors and CHM for RA. The methodological quality of the included studies was evaluated using the risk of bias assessment tool. Meta-analyses were performed for RF， anti-CCP， ESR， CRP， 28-joint disease activity score （DAS28）， overall clinical effective rate， and incidence of adverse events. Sensitivity analysis were also performed. ResultsThe retrospective study demonstrated that after treatment， ESR， CRP， and anti-CCP levels decreased in the observation group， while ESR and CRP levels decreased in the control group （P＜0.05）. Moreover， ESR and RF levels in the observation group were lower than those in the control group （P＜0.05）. A total of 9 RCTs involving 770 patients were included in the meta-analysis. The results indicated that the JAK inhibitors plus CHM group was superior to the JAK inhibitors group in reducing RF （MD=-8.97， 95%CI -15.01 to -2.94， P=0.004）， CRP （MD=-3.34， 95%CI -3.82 to -2.86， P＜0.001）， ESR （MD=-5.33， 95%CI -7.98 to -2.69， P＜0.001）， and DAS28 score （MD=-0.54， 95%CI -0.74 to -0.34， P＜0.001）， as well as in improving the overall clinical effective rate （OR=4.53， 95%CI 2.55 to 8.03， P＜0.001）. No statistically significant differences were observed between groups in anti-CCP levels （SMD=-2.08， 95%CI -4.41 to 0.24， P=0.080） or incidence of adverse events （OR=0.93， 95%CI 0.55 to 1.57， P=0.790）. ConclusionThe combination of JAK inhibitors and CHM demonstrates remarkable efficacy in treating RA， contributing to improved disease activity and reduced inflammatory markers with a favorable safety profile.

Objective:To qualitatively and quantitatively compare and evaluate the application of the Fast BLADE sequence and the conventional BLADE sequence in 3T magnetic resonance (MR) liver T2-weighted imaging (T2WI).Methods:A total of 72 patients who underwent liver MR examination at the Chongqing People′s Hospital from December 2023 to July 2024 were selected. All patients underwent liver magnetic resonance imaging (MRI) scanning using a 3T MR scanner, including both the Fast BLADE sequence and the conventional BLADE sequence. The total imaging time of the two sequences was recorded. Two observers used a " 5-point scale" to evaluate the overall image quality, motion artifacts, and radial artifacts of the Fast BLADE and conventional BLADE sequences respectively, and measured the image signal-to-noise ratio (SNR) at the same spatial position in the two groups of images. Statistical analysis was used to evaluate the differences in imaging time and image quality between the Fast BLADE sequence and the conventional BLADE sequence in liver T2WI imaging.Results:The imaging time of the Fast BLADE sequence in liver T2WI imaging was significantly shorter than that of the conventional BLADE sequence ( P<0.01), and the image SNR was significantly higher than that of the conventional BLADE sequence ( P<0.01). The overall image quality, motion artifact reduction, and radial artifact reduction of the Fast BLADE sequence were all superior to those of the conventional BLADE sequence (all P<0.05). The Kappa coefficients for the consistency of the two observers′ evaluations on overall image quality, motion artifacts, and radial artifacts were 0.78, 0.66, and 0.71 respectively. Conclusions:The Fast BLADE sequence can shorten the imaging time and provide images with higher SNR, and thus can replace the conventional BLADE sequence for liver T2WI imaging.

Objective:To qualitatively and quantitatively compare and evaluate the application of the Fast BLADE sequence and the conventional BLADE sequence in 3T magnetic resonance (MR) liver T2-weighted imaging (T2WI).Methods:A total of 72 patients who underwent liver MR examination at the Chongqing People′s Hospital from December 2023 to July 2024 were selected. All patients underwent liver magnetic resonance imaging (MRI) scanning using a 3T MR scanner, including both the Fast BLADE sequence and the conventional BLADE sequence. The total imaging time of the two sequences was recorded. Two observers used a " 5-point scale" to evaluate the overall image quality, motion artifacts, and radial artifacts of the Fast BLADE and conventional BLADE sequences respectively, and measured the image signal-to-noise ratio (SNR) at the same spatial position in the two groups of images. Statistical analysis was used to evaluate the differences in imaging time and image quality between the Fast BLADE sequence and the conventional BLADE sequence in liver T2WI imaging.Results:The imaging time of the Fast BLADE sequence in liver T2WI imaging was significantly shorter than that of the conventional BLADE sequence ( P<0.01), and the image SNR was significantly higher than that of the conventional BLADE sequence ( P<0.01). The overall image quality, motion artifact reduction, and radial artifact reduction of the Fast BLADE sequence were all superior to those of the conventional BLADE sequence (all P<0.05). The Kappa coefficients for the consistency of the two observers′ evaluations on overall image quality, motion artifacts, and radial artifacts were 0.78, 0.66, and 0.71 respectively. Conclusions:The Fast BLADE sequence can shorten the imaging time and provide images with higher SNR, and thus can replace the conventional BLADE sequence for liver T2WI imaging.